Logo image of OSTK

OVERSTOCK.COM INC (OSTK) Stock Fundamental Analysis

USA - NASDAQ:OSTK - US6903701018 - Common Stock

16.78 USD
+0.87 (+5.47%)
Last: 11/3/2023, 8:14:30 PM
17 USD
+0.22 (+1.31%)
After Hours: 11/3/2023, 8:14:30 PM
Fundamental Rating

2

OSTK gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 122 industry peers in the Specialty Retail industry. The financial health of OSTK is average, but there are quite some concerns on its profitability. OSTK is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year OSTK has reported negative net income.
OSTK had a negative operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: OSTK reported negative net income in multiple years.
The reported operating cash flow has been mixed in the past 5 years: OSTK reported negative operating cash flow in multiple years.
OSTK Yearly Net Income VS EBIT VS OCF VS FCFOSTK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 0 100M -100M 200M -200M 300M

1.2 Ratios

The Return On Assets of OSTK (-16.97%) is worse than 81.68% of its industry peers.
OSTK has a worse Return On Equity (-24.00%) than 64.12% of its industry peers.
Industry RankSector Rank
ROA -16.97%
ROE -24%
ROIC N/A
ROA(3y)11.65%
ROA(5y)-7.67%
ROE(3y)18.42%
ROE(5y)-41.02%
ROIC(3y)N/A
ROIC(5y)N/A
OSTK Yearly ROA, ROE, ROICOSTK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 0 -50 -100 -150

1.3 Margins

OSTK's Gross Margin of 22.84% is on the low side compared to the rest of the industry. OSTK is outperformed by 75.57% of its industry peers.
OSTK's Gross Margin has improved in the last couple of years.
OSTK does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 22.84%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.63%
GM growth 5Y3.32%
OSTK Yearly Profit, Operating, Gross MarginsOSTK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 0 10 -10 20

5

2. Health

2.1 Basic Checks

OSTK does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for OSTK has been increased compared to 1 year ago.
Compared to 1 year ago, OSTK has a worse debt to assets ratio.
OSTK Yearly Shares OutstandingOSTK Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 10M 20M 30M 40M
OSTK Yearly Total Debt VS Total AssetsOSTK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 200M 400M 600M 800M 1B

2.2 Solvency

OSTK has an Altman-Z score of 3.78. This indicates that OSTK is financially healthy and has little risk of bankruptcy at the moment.
OSTK has a better Altman-Z score (3.78) than 80.15% of its industry peers.
OSTK has a Debt/Equity ratio of 0.06. This is a healthy value indicating a solid balance between debt and equity.
OSTK has a better Debt to Equity ratio (0.06) than 74.81% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF N/A
Altman-Z 3.78
ROIC/WACCN/A
WACC9.19%
OSTK Yearly LT Debt VS Equity VS FCFOSTK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 0 200M 400M 600M

2.3 Liquidity

OSTK has a Current Ratio of 1.97. This is a normal value and indicates that OSTK is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of OSTK (1.97) is better than 77.86% of its industry peers.
A Quick Ratio of 1.94 indicates that OSTK should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.94, OSTK belongs to the top of the industry, outperforming 87.79% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.97
Quick Ratio 1.94
OSTK Yearly Current Assets VS Current LiabilitesOSTK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 100M 200M 300M 400M 500M

1

3. Growth

3.1 Past

OSTK shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -102.27%.
Looking at the last year, OSTK shows a very negative growth in Revenue. The Revenue has decreased by -42.51% in the last year.
The Revenue has been growing slightly by 2.03% on average over the past years.
EPS 1Y (TTM)-102.27%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-110.53%
Revenue 1Y (TTM)-42.51%
Revenue growth 3Y10.37%
Revenue growth 5Y2.03%
Sales Q2Q%-60.32%

3.2 Future

The Earnings Per Share is expected to grow by 12.97% on average over the next years. This is quite good.
The Revenue is expected to decrease by -0.93% on average over the next years.
EPS Next Y-352.74%
EPS Next 2Y-106.12%
EPS Next 3Y-22.55%
EPS Next 5Y12.97%
Revenue Next Year-19.05%
Revenue Next 2Y-6.61%
Revenue Next 3Y-2.73%
Revenue Next 5Y-0.93%

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
OSTK Yearly Revenue VS EstimatesOSTK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B 2B 2.5B
OSTK Yearly EPS VS EstimatesOSTK Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 2 -2 -4 -6

0

4. Valuation

4.1 Price/Earnings Ratio

OSTK reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for OSTK. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
OSTK Price Earnings VS Forward Price EarningsOSTK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -200 -400

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of OSTK indicates a slightly more expensive valuation: OSTK is more expensive than 65.65% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 48.99
OSTK Per share dataOSTK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

A cheap valuation may be justified as OSTK's earnings are expected to decrease with -22.55% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-106.12%
EPS Next 3Y-22.55%

0

5. Dividend

5.1 Amount

No dividends for OSTK!.
Industry RankSector Rank
Dividend Yield N/A

OVERSTOCK.COM INC

NASDAQ:OSTK (11/3/2023, 8:14:30 PM)

After market: 17 +0.22 (+1.31%)

16.78

+0.87 (+5.47%)

Chartmill FA Rating
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)10-26 2023-10-26/bmo
Earnings (Next)02-20 2024-02-20/amc
Inst Owners63.52%
Inst Owner Change5.69%
Ins Owners4.25%
Ins Owner Change0%
Market Cap760.13M
Analysts71.76
Price Target22.95 (36.77%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)57.31%
Min EPS beat(2)36.41%
Max EPS beat(2)78.21%
EPS beat(4)3
Avg EPS beat(4)-38.5%
Min EPS beat(4)-296.08%
Max EPS beat(4)78.21%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)2.78%
Min Revenue beat(2)1.03%
Max Revenue beat(2)4.52%
Revenue beat(4)2
Avg Revenue beat(4)-2.64%
Min Revenue beat(4)-11.53%
Max Revenue beat(4)4.52%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-41.05%
PT rev (3m)-47.27%
EPS NQ rev (1m)-10.42%
EPS NQ rev (3m)-154.86%
EPS NY rev (1m)5.79%
EPS NY rev (3m)-76.5%
Revenue NQ rev (1m)-0.26%
Revenue NQ rev (3m)-4.01%
Revenue NY rev (1m)0.18%
Revenue NY rev (3m)-2.57%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.46
P/FCF N/A
P/OCF N/A
P/B 1.33
P/tB 1.4
EV/EBITDA 48.99
EPS(TTM)-0.03
EYN/A
EPS(NY)-1.15
Fwd EYN/A
FCF(TTM)-1.3
FCFYN/A
OCF(TTM)-0.34
OCFYN/A
SpS36.83
BVpS12.65
TBVpS11.95
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -16.97%
ROE -24%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 22.84%
FCFM N/A
ROA(3y)11.65%
ROA(5y)-7.67%
ROE(3y)18.42%
ROE(5y)-41.02%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)11.82%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.63%
GM growth 5Y3.32%
F-Score3
Asset Turnover2.06
Health
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF N/A
Debt/EBITDA 3.7
Cap/Depr 230.01%
Cap/Sales 2.6%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.97
Quick Ratio 1.94
Altman-Z 3.78
F-Score3
WACC9.19%
ROIC/WACCN/A
Cap/Depr(3y)74.77%
Cap/Depr(5y)83.05%
Cap/Sales(3y)0.68%
Cap/Sales(5y)1.13%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-102.27%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-110.53%
EPS Next Y-352.74%
EPS Next 2Y-106.12%
EPS Next 3Y-22.55%
EPS Next 5Y12.97%
Revenue 1Y (TTM)-42.51%
Revenue growth 3Y10.37%
Revenue growth 5Y2.03%
Sales Q2Q%-60.32%
Revenue Next Year-19.05%
Revenue Next 2Y-6.61%
Revenue Next 3Y-2.73%
Revenue Next 5Y-0.93%
EBIT growth 1Y-111.38%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-264.4%
EBIT Next 3Y3.2%
EBIT Next 5Y17.06%
FCF growth 1Y-151.85%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-112.08%
OCF growth 3YN/A
OCF growth 5YN/A